Management of bone disease in patients on long term glucocorticoid therapy

Gut

Volumn 44, Issue 6, 1999, Pages 770-772

  Compston, J E ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ALFACALCIDOL; BISPHOSPHONIC ACID DERIVATIVE; BUDESONIDE; CALCITONIN; CALCITRIOL; CALCIUM; COLLAGEN TYPE 1; DEFLAZACORT; ESTROGEN; ETIDRONIC ACID; FLUORIDE SODIUM; GLUCOCORTICOID; OSTEOCALCIN; PHOSPHATE; PREDNISOLONE; SEX HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C; TESTOSTERONE; TRANSFORMING GROWTH FACTOR BETA; VITAMIN D;

BONE DISEASE; DRUG INDUCED DISEASE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL TOXICITY; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; LIFESTYLE; LONG TERM CARE; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; SECONDARY PREVENTION;

EID: 0032982197     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.44.6.770     Document Type: Review

References (30)

1. Compston JE. Osteoporosis, corticosteroids and inflammatory bowel disease. Aliment Pharmacol Ther 1995;9:237-50.
2. Peat ID, Reid DM, Ralston SH. Steroid-induced osteoporosis an opportunity for prevention. Ann Rheum Dis 1995;54:66-8.
3. Walsh LJ, Wong CA, Pringle M, et al. Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: A cross sectional study. BMJ 1996;313:344-6.
4. Adachi JD, Bensen WG, Brown J, et al. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med 1997;337:382-7.
5. Saag KG, Emkey R, Schnitzer TJ, et al. Alendronate for the prevention and treatment of glucorticoid-induced osteoporosis. N Engl J Med 1998;339: 292-9.
6. Sambrook P, Birmingham J, Kelly P, et al. Corticosteroid effects on proximal femur bone loss. J Bone Miner Res 1990;5:1211-16.
7. Sambrook P, Birmingham J, Kelly P, et al. Prevention of corticosteroid osteoporosis-a comparison of calcium, calcitriol and calcitonin. N Engl J Med 1993;328:1747-52.
8. Marystone JF, Barrett Connor L, Morton DJ. Inhaled and oral corticosteroids: Their effects on bone mineral density in older adults. Am J Public Health 1995;85:1693-5.
9. Hooyman JR, Melton LJ, Nelson AM, et al. Fractures after rheumatoid arthritis-a population based study. Arthritis Rheum 1984;27:1353-61.
10. Cooper C, Coupland C, Mitchell M. Rheumatoid arthritis, corticosteroid therapy and the risk of hip fracture. Am Rheum Dis 1995;54:49-52.
11. Struys A, Snelder AA, Mulder H. Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis. Am J Med 1995;99:235-42.
12. Sambrook PN, Eisman JA, Yeates MG, et al. Osteoporosis in rheumatoid arthritis-safety or low dose. Ann Rheum Dis 1986;45:950-3.
13. Buckley LM, Leib ES, Cartulato KS, et al. Effects of low-dose corticosteroids on the bone-mineral density of patients with rheumatoid arthritis. J Rheumatol 1995;22:1055-9.
14. Pocock NA, Eisman JA, Dunstan CR, et al. Recovery from steroid-induced osteoporosis. Ann Intern Med 1987;107:319-23.
15. Cino M, Greenberg GR. Bone mineral density in Crohn's disease patients receiving long-term budesonide. Gastroenterology 1998;114:G3902.
16. Gluck SO, Murphy WA, Hahn TJ, et al. Bone loss in adults receiving alternate day glucocorticoid therapy. A comparison with daily therapy. Arthritis Rheum 1981;24:892-8.
17. Lukert B. Glucocorticoid-induced osteoporosis. In: Marcus R, Feldman D. Kelsey J, eds. Osteoporosis. San Diego: Academic Press Inc, 1996:801-20.
18. Ushida Y, Heersche JNM. Glucocorticoid-induced osteoporosis: both in vivo and in vitro concentrations of glucocorticoids higher than physiological levels attenuate osteoblast differentiation. J Bone Miner Res 1998;13: 1822-6.
19. Cosman F, Nieves J, Herbert J, et al. High-dose glucocorticoids in multiple sclerosis patients exert direct effects on the kidney and skeleton. J Bone Miner Res 1994;9:1097-105.
20. Dempster DW. Bone histomorphometry in glucocorticoid-induced osteoporosis. J Bone Miner Res 1989;4:137-47.
21. Aaron JE, Francis RM, Peacock M, et al. Contrasting microanatomy of idiopathic and corticosteroid-induced osteoporosis. Clin Orthop 1989;243:294-305.
22. Luengo M, Picado C, Del Rio L, et al. Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study. Thorax 1991;46:803-6.
23. Compston JE, Reginster J-Y, Avouac B. Recommendations for the registration of agents used in the prevention and treatment of glucocorticoid-induced osteoporosis. Calcif Tissue Int 1996;59:323-7.
24. Eastell R, Reid DM, Compston JE, et al. A UK consensus group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med 1998;244:271-92.
25. De Groen PC, Lubbe DF, Hirsch LJ. Esophagitis associated with the use of alendronate. N Engl J Med 1996;335:1016-21.
26. Löfberg R, Thomsen OO, Langholz E, et al. Budesonide vs. prednisolone retention enemas in active ulcerative colitis. Aliment Pharmacol Ther 1994; 8:623-9.
27. Adachi JD, Bensen WG, Bianchi F, et al. Vitamin D and calcium in the prevention of corticosteroid-induced osteoporosis. J Rheumatol 1996;23:995-1000.
28. Buckley LM, Leib ES, Cartularo KS, et al. Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1996;125:961-8.
29. Lukert BP, Johnson BE, Robinson RG. Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss. J Bone Miner Res 1992;7:1063-9.
30. Reid IR, Wattie DJ, Evans MC, et al. Testosterone therapy in glucocorticoid-treated men. Arch Intern Med 1996;156:1173-7.